Christian Jakob

3.7k total citations
77 papers, 2.7k citations indexed

About

Christian Jakob is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Christian Jakob has authored 77 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 38 papers in Molecular Biology and 36 papers in Oncology. Recurrent topics in Christian Jakob's work include Multiple Myeloma Research and Treatments (35 papers), Peptidase Inhibition and Analysis (17 papers) and Ubiquitin and proteasome pathways (16 papers). Christian Jakob is often cited by papers focused on Multiple Myeloma Research and Treatments (35 papers), Peptidase Inhibition and Analysis (17 papers) and Ubiquitin and proteasome pathways (16 papers). Christian Jakob collaborates with scholars based in Germany, Portugal and United States. Christian Jakob's co-authors include Orhan Sezer, Ulrike Heider, Ivana Zavrski, Claudia Fleissner, Martin Kaiser, Jan Eucker, Kurt Possinger, Jan Sterz, Kathrin Niemöller and Lorenz Kleeberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Chemical Communications.

In The Last Decade

Christian Jakob

74 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christian Jakob Germany 31 1.5k 1.3k 1.2k 236 228 77 2.7k
Sonia Vallet United States 31 1.8k 1.2× 1.4k 1.1× 1.5k 1.2× 322 1.4× 239 1.0× 104 3.3k
Diana Cirstea United States 22 1.6k 1.1× 894 0.7× 1.1k 0.9× 168 0.7× 141 0.6× 80 2.4k
Francis J. Giles United States 28 1.0k 0.7× 884 0.7× 772 0.6× 408 1.7× 345 1.5× 50 2.6k
Andrew J. Yee United States 26 1.4k 0.9× 1.0k 0.8× 1.1k 0.9× 250 1.1× 131 0.6× 127 2.3k
Mohit Trikha United States 29 1.2k 0.8× 574 0.5× 930 0.8× 161 0.7× 384 1.7× 55 2.5k
Alvin Wong United States 25 1.0k 0.7× 693 0.5× 726 0.6× 201 0.9× 200 0.9× 72 2.0k
Ji Yuan Wu United States 21 712 0.5× 908 0.7× 666 0.6× 803 3.4× 173 0.8× 44 2.1k
Lance Leopold United States 24 1.1k 0.7× 473 0.4× 1.4k 1.1× 215 0.9× 307 1.3× 50 2.8k
Luanda Grazette United States 15 1.1k 0.7× 345 0.3× 802 0.7× 175 0.7× 82 0.4× 44 2.8k
Laetitia Devy Belgium 24 1.5k 1.0× 427 0.3× 1.3k 1.1× 143 0.6× 1.0k 4.4× 33 3.1k

Countries citing papers authored by Christian Jakob

Since Specialization
Citations

This map shows the geographic impact of Christian Jakob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Jakob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Jakob more than expected).

Fields of papers citing papers by Christian Jakob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Jakob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Jakob. The network helps show where Christian Jakob may publish in the future.

Co-authorship network of co-authors of Christian Jakob

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Jakob. A scholar is included among the top collaborators of Christian Jakob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Jakob. Christian Jakob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakob, Christian, Corazon Frias, Fernanda Marques, et al.. (2021). Gold(I) Bis(1,2,3-triazol-5-ylidene) Complexes as Promising Selective Anticancer Compounds. Journal of Medicinal Chemistry. 64(21). 15747–15757. 25 indexed citations
2.
Anneser, Markus R., et al.. (2021). Mimicking reactive high-valent diiron-μ2-oxo intermediates of nonheme enzymes by an iron tetracarbene complex. Chemical Communications. 57(54). 6644–6647. 10 indexed citations
3.
Jakob, Christian, et al.. (2021). Fluorescent palladium(ii) and platinum(ii) NHC/1,2,3-triazole complexes: antiproliferative activity and selectivity against cancer cells. Dalton Transactions. 50(6). 2158–2166. 16 indexed citations
4.
Jakob, Christian, et al.. (2021). Degradation pathways of a highly active iron(iii) tetra-NHC epoxidation catalyst. Catalysis Science & Technology. 11(3). 795–799. 9 indexed citations
5.
Jakob, Christian, Julia Rieb, Christian Jandl, et al.. (2020). Dinuclear Gold(I) Complexes Bearing N,N′‐Allyl‐Bridged Bisimidazolylidene Ligands. Chemistry - An Asian Journal. 15(12). 1848–1851. 8 indexed citations
6.
Jakob, Christian, et al.. (2020). Anticancer and antibacterial properties of trinuclear Cu(I), Ag(I) and Au(I) macrocyclic NHC/urea complexes. Journal of Organometallic Chemistry. 932. 121643–121643. 41 indexed citations
7.
Jakob, Christian, Teresa Pinheiro, Fernanda Marques, et al.. (2020). Antiproliferative Activity of Functionalized Histidine‐derived Au(I) bis‐NHC Complexes for Bioconjugation. Chemistry - An Asian Journal. 15(17). 2754–2762. 20 indexed citations
8.
Jakob, Christian, et al.. (2020). Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification. Chemistry - An Asian Journal. 15(24). 4275–4279. 11 indexed citations
9.
Jakob, Christian, et al.. (2019). Reactivity Studies of a Dipyridine Ethinyl Ligand with Zinc(II). European Journal of Inorganic Chemistry. 2019(48). 5059–5065. 2 indexed citations
10.
11.
12.
Jakob, Christian, Evangelos Terpos, Jan Sterz, et al.. (2009). Serum Levels of Total-RANKL in Multiple Myeloma. Clinical Lymphoma & Myeloma. 9(6). 430–435. 24 indexed citations
13.
Heider, Ulrike, Martin Kaiser, Jan Sterz, et al.. (2005). Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. European Journal Of Haematology. 76(1). 42–50. 66 indexed citations
14.
Zavrski, Ivana, Christian Jakob, Peter Schmid, et al.. (2005). Proteasome: an emerging target for cancer therapy. Anti-Cancer Drugs. 16(5). 475–481. 57 indexed citations
15.
Heider, Ulrike, Claudia Fleissner, Ivana Zavrski, et al.. (2003). Treatment of refractory chronic lymphocytic leukemia with Campath‐1H in combination with lamivudine in chronic hepatitis B infection. European Journal Of Haematology. 72(1). 64–66. 12 indexed citations
16.
Jakob, Christian, Ivana Zavrski, Ulrike Heider, et al.. (2003). Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.. PubMed. 9(8). 3047–51. 26 indexed citations
17.
Niemöller, Kathrin, Christian Jakob, Ulrike Heider, et al.. (2003). Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III. Journal of Cancer Research and Clinical Oncology. 129(4). 234–238. 27 indexed citations
18.
Eucker, Jan, Peter Schmid, Christian Jakob, et al.. (2002). The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkinʼs lymphomas. Anti-Cancer Drugs. 13(9). 907–913. 8 indexed citations
19.
Sezer, Orhan, Kathrin Niemöller, Christian Jakob, et al.. (2001). Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma. Annals of Hematology. 80(10). 598–601. 36 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Vallet Breakdown of academic impact, for papers by Diana Cirstea Breakdown of academic impact, for papers by Francis J. Giles Breakdown of academic impact, for papers by Andrew J. Yee Breakdown of academic impact, for papers by Mohit Trikha Breakdown of academic impact, for papers by Alvin Wong Breakdown of academic impact, for papers by Ji Yuan Wu Breakdown of academic impact, for papers by Lance Leopold Breakdown of academic impact, for papers by Luanda Grazette Breakdown of academic impact, for papers by Laetitia Devy
Rankless by CCL
2026